Clinical Trial Update: Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase I/II trial evaluating mitoxantrone, etoposide, and gemtuzumab ozogamicin for acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Etoposide (Etoposide)
• Mylotarg (gemtuzumab ozogamicin)
• Novantrone (mitoxantrone)

Snippet

Sponsor: University of Pittsburgh | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED